Beam Therapeutics had seven patents in advanced materials during Q4 2023. Beam Therapeutics Inc filed patents in Q4 2023 related to compositions, preparations, nanoparticles (such as lipid nanoparticles), nanomaterials, and methods of their use. GlobalData’s report on Beam Therapeutics gives a 360-degreee view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Premium Insights Beam Therapeutics Inc - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

Beam Therapeutics grant share with advanced materials as a theme is 0% in Q4 2023. Grant share is based on the ratio of number of grants to total number of patents.

Recent Patents

Application: Nanomaterials comprising carbonates (Patent ID: US20230357133A1)

The patent filed by Beam Therapeutics Inc. describes compositions, preparations, nanoparticles, and nanomaterials for use in various methods. The compounds described in the patent have specific structural formulas and can be used in the preparation of lipid nanoparticles (LNPs) for pharmaceutical applications. The patent covers a wide range of compounds and their pharmaceutically acceptable salts, providing a detailed description of their chemical structures and potential applications.

Furthermore, the patent claims cover the use of these compounds in LNP preparations for delivering therapeutic and prophylactic agents to subjects in need. The methods described in the patent include administering the LNP preparations to treat diseases or disorders, delivering therapeutic agents to mammalian cells, producing specific polypeptides of interest, inhibiting the production of certain polypeptides, and targeting specific mammalian organs. Overall, the patent outlines a comprehensive approach to utilizing these compounds in the development of pharmaceutical compositions and methods for targeted drug delivery and treatment strategies.

To know more about GlobalData’s detailed insights on Beam Therapeutics, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.